General pharmacology of indole [2′,3′:3,4] pyrido [2,1-b] quinazolinium-5,7,8,13- tetrahydro-14-methyl-5-oxochloride, a new anti-dementia agent

Arzneimittel-Forschung/Drug Research

Volumn 53, Issue 6, 2003, Pages 393-401

  Park, Cheol Hyoung ^a   Choi, Se Hoon ^a   Kim, Chan Hyung ^a   Seo, Ji Heui ^a   Koo, Ja Wook ^a   Rah, Jong Cheol ^a   Kim, Hye Sun ^a   Jeong, Sung Jin ^a   Joo, Wan Seok ^a   Lee, Young Jae ^b   Kim, Yong Sik ^a   Kim, Myung Suk ^a   Suh, Yoo Hun ^a  

^a Seoul National University   (South Korea)

^b Jeju National University   (South Korea)

Author keywords

Anti dementia agent; CAS 67909 49 3; Evodia rutaecarpa; Indole 2 ,3 :3,4 pyrido 2,1 b quinazolinium 5,7,8,13 tetrahydro 14 methyl 5 oxo chloride, general pharmacology, mouse, rabbit, rat

Indexed keywords

DEHYDROEVODIAMINE; INDOLO[2',3':3,4]PYRIDO[2,1 B]QUINAZOLINIUM 5,7,8,13 TETRAHYDRO 14 METHYL 5 OXOCHLORIDE; NOOTROPIC AGENT; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD CLOTTING; BLOOD PRESSURE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; DRUG STRUCTURE; FEMALE; GASTROINTESTINAL TRACT; HEART RATE; ILEUM; LIVER FUNCTION; MALE; MEMORY; MOUSE; NONHUMAN; RABBIT; RAT; SMOOTH MUSCLE; VAS DEFERENS;

EID: 0038095662     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1297126     Document Type: Article

References (15)

1. Giacobini, E., From molecular structure to Alzheimer therapy. Jpn. J. Pharmacol. 74, 225 (1997)
2. Arisawa, M., Horiuchi, T., Hayashi, T. et al., Studies on Constituents of Evodia rutaecarpa (Rutaceae). I. Constituents of the leaves. Chem. Pharm. Bull. 41, 1472 (1993)
3. Park, C. H., Kim, S. H., Choi, W. et al., Novel anticholinesterase and antiamnesic activities of dehydroevodiamine, a constituent of Evodia rutaecarpa. Planta Med. 62, 405 (1996)
4. Park, C. H., Lee, Y. J., Lee, S. H. et al., Dehydroevodiamine. HCl prevents impairment of learning and memory and neuronal loss in rat models of cognitive disturbance. J. Neurochem. 74, 244 (2000)
5. Haji, A., Momose, Y., Takeda, R. et al., Increase feline cerebral blood flow induced by dehydroevodiamine Hydrochloride from Evodica rutaecarpa. J. Nat. Prod. 57, 387 (1994)
6. Irwin, S., Animal and Clinical Pharmacologic Techniques in Drug Evaluation, J. H. Nodine, P. E. Siegler (eds.), pp. 36, Year Book Medical Publishers Inc., Chicago (1964)
7. Horst, W. D., Pool, W. R., Spiegel, H. E., Correlation between dopamine levels and 1-dopa activity in anti-Parkinson tests. Eur. J. Pharmacol. 21, 337 (1973)
8. Courvoisior, S., Ductot, R., Julon, L., Psychotropic drugs, pp. 373, Elsevier, Amsterdam (1957)
9. Koster, R., Anderson, M., de Beer, E. J., Acetic acid for analgesic screening. Red. Proc. 18, 412 (1959)
10. Schreiber, R. A., Schlesinger, K., Circadian rhythms and seizure susceptibility: Relation to 5-hydroxytryptamine and norepinephrine in brain. Physiol. Behav. 6, 635 (1971)
11. Schechter, P. J., Tranier, Y., Jung, M. J. et al., Antiseizure activity of γ-acetylenic γ-aminobutyric acid: A catalytic irreversible inhibitor of γ-aminobutyric acid transaminase. J. Pharmacol. Exp. Ther. 201, 606 (1977)
12. Wahlestedt, C., Wohlfart, B., Hakanson, R., Effects of neuropeptide Y (NPY) on isolated guinea-pig heart. Acta Physiol. Scand. 129, 459 (1987)
13. Matsuda, H., Wu, J. X., Tanaka, T. et al., Antinociceptive activities of 70% methanol extract of evodiae fruits (fruit of Evodia rutaecarpa var. bodinieri) and its alkaloidal components. Biol. Pharm. Bull. 20, 243 (1997)
14. Matsuda, H., Yoshikawa, M., Linuma, M. et al., Antinociceptive and anti-inflammatory activities of limonin isolated from the fruits of Evodia rutaecarpa var. bodinieri. Planta Med. 64, 339 (1998)
15. Chiou, W., Chou, C., Shum, A. et al., The vasorelaxant effect of evodiamine in rat isolated mesenteric arteries: mode of action. Eur. J. Pharmacol. 14, 277 (1992)